Showing results (261-270 of 322) with videos related to
Sort By:
Pageof 33
Blood|March 26, 1999
Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working PartyJ Marsh, H Schrezenmeier, P Marin, et al.Bone Marrow Transplantation|November 1, 2006
Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donorsJ M Hows, J R Passweg, A Tichelli, et al.Bone Marrow Transplantation|June 2, 2015
Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantationL von Bahr, O Blennow, J Alm, et al.Bone Marrow Transplantation|January 8, 2008
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched graftsG Giraud, P Priftakis, G Bogdanovic, et al.Journal of Medical Virology|November 14, 2000
Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological studyM Enbom, J Sheldon, E Lennette, et al.Bone Marrow Transplantation|November 1, 1996
Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working PartyG Dini, R Rondelli, M Miano, et al.Bone Marrow Transplantation|December 14, 2011
Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapyP Ljungman, A Locasciulli, V G de Soria, et al.Bone Marrow Transplantation|July 1, 1997
Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutisG Michel, F Boulad, T N Small, et al.Annals of Internal Medicine|February 27, 1999
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working PartyA Tichelli, G Socié, M Henry-Amar, et al.Bone Marrow Transplantation|February 21, 2007
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseasesO Ringdén, M Remberger, P Svenberg, et al.Pageof 33